Gritstone bio, Inc. (GRTS) Tops Q2 EPS by 4c

Gritstone bio, Inc. (NASDAQ: GRTS) reported Q2 EPS of ($0.31), $0.04 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.96 million versus the consensus estimate of $2.51 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Qualcomm investor day to detail data center plans Wednesday
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen